Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure (2010)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; ZATZ, ROBERTO - FM ; FUJIHARA, CLARICE KAZUE - FM
- Unidade: FM
- Subjects: PRESSÃO SANGUÍNEA (CONTROLE); INSUFICIÊNCIA RENAL CRÔNICA; INSUFICIÊNCIA CARDÍACA; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
VALENTE, C P et al. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 13 fev. 2026. , 2010 -
APA
Valente, C. P., Costa, S. R., Sena, C. R., Fanelli, C., Ventura, B. H., David, D. S. R., et al. (2010). Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Valente CP, Costa SR, Sena CR, Fanelli C, Ventura BH, David DSR, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. 2010 ; 65 S58.[citado 2026 fev. 13 ] -
Vancouver
Valente CP, Costa SR, Sena CR, Fanelli C, Ventura BH, David DSR, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure. Clinics. 2010 ; 65 S58.[citado 2026 fev. 13 ] - Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
- NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy
- High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac)
- Regression of diabetic nephropathy: no dose-response effect of an angiotensin II antagonist
- An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
